Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Nachbaur

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
A series of infections due to Capnocytophaga spp in immunosuppressed and immunocompetent patientsH Bonatti, D W Rossboth, D Nachbaur, et al.
International Journal of Laboratory Hematology|June 5, 2008
T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantationB Kircher, D Niederwieser, A Gächter, et al.
Blood|August 15, 1996
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancerB Eibl, H Schwaighofer, D Nachbaur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studiesH Ludwig, A M Cohen, A Polliack, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: interim resultsH Ludwig, A M Cohen, H Huber, et al.
Transplantation|January 15, 1997
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapyH Schwaighofer, G Oberhuber, H Hebart, et al.
Transplantation Proceedings|November 5, 2013
The liver graft as Trojan horse-multilineage donor-derived hematopoiesis after liver transplantation: case reportW Mark, R Ollinger, H Rumpold, et al.
Annals of Hematology|April 7, 2026
Long enduring response on teclistamab in a patient with myeloma relapse after allogeneic hematopoietic stem cell transplantation - a case reportP Ebner, J Fauser, G Hetzenauer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Journal of Nephrology|December 31, 2020
Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injuryN Steiner, A Abdel Hamid, A Kronbichler, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
A series of infections due to Capnocytophaga spp in immunosuppressed and immunocompetent patientsH Bonatti, D W Rossboth, D Nachbaur, et al.
International Journal of Laboratory Hematology|June 5, 2008
T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantationB Kircher, D Niederwieser, A Gächter, et al.
Blood|August 15, 1996
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancerB Eibl, H Schwaighofer, D Nachbaur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studiesH Ludwig, A M Cohen, A Polliack, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: interim resultsH Ludwig, A M Cohen, H Huber, et al.
Transplantation|January 15, 1997
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapyH Schwaighofer, G Oberhuber, H Hebart, et al.
Transplantation Proceedings|November 5, 2013
The liver graft as Trojan horse-multilineage donor-derived hematopoiesis after liver transplantation: case reportW Mark, R Ollinger, H Rumpold, et al.
Annals of Hematology|April 7, 2026
Long enduring response on teclistamab in a patient with myeloma relapse after allogeneic hematopoietic stem cell transplantation - a case reportP Ebner, J Fauser, G Hetzenauer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Journal of Nephrology|December 31, 2020
Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injuryN Steiner, A Abdel Hamid, A Kronbichler, et al.
Pageof 7